[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Page 28076]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-9651]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 26, 2006, and published in the Federal 
Register on August 2, 2006, (71 FR 43814), Noramco Inc., 1440 Olympic 
Drive, Athens, Georgia 30601, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Methylphenidate (1724), a basic class of controlled 
substance listed in schedule II.
    The company plans to bulk manufacture methylphenidate for a 
customer to use in the production of a controlled substance product.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Noramco Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Noramco Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with State and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-9651 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P